| MT 2091 5,6-Dimethylxanthenone-4-acetic acid, [3H]- | |
| (DMXAA, [3H]-; Vadimezan, [3H]-) | |
|
MORpure™
Delivered ≥ 97% pure with dated HPLC radiochromatogram
|
|
| Ethanol solution, 1.0 mCi/ml | |
| > 15 Ci(555 GBq)/mmol | 50 µCi (1.85 MBq) $1160 |
| NextGen V-Vial - shipped on dry ice | 250 µCi (9.25 MBq) $1970 |
M.W. 282.29  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |